Bluejay diagnostics reports 2022 financial results

Acton, mass., march 20, 2023 (globe newswire) -- bluejay diagnostics, inc. (nasdaq: bjdx) (“bluejay” or the “company”), a medical diagnostics company developing rapid tests using whole blood on its symphony platform to improve patient outcomes in critical care settings, today reported its financial results for the year ended december 31, 2022.
BJDX Ratings Summary
BJDX Quant Ranking